Skip to main content
Skip to section navigation
Skip to footer
Careers
News & Media
Contact
Therapies
Overview
Ngenla
Rayaldee
Research
Overview
Pipeline
Publications
Scientific Presentations
Diagnostics
Company
Overview
Leadership
Locations
Partnerships
Investors
Overview
News / Events
Presentations
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Careers
News & Media
Contact
Press Releases
Investors
Investors
Overview
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Presentations
Company Info
Overview
Proxy Materials
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Form 8937
Governance
Overview
Management Team
Board of Directors
Board Committees
Governance Documents
Year
All Years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Category
All Releases
Financial Releases
Jul 11, 2007 8:00am EDT
Opko Health Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD
Previous Page
arrow_back
Page
1
…
Page
43
Page
44
Page
45
Page
46
Page
47
Page
48
Page
49
Page
50
Page
51
Page
52
Select a page:
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Page 52
rss_feed
News RSS
email
Email Alerts
location_city
Company Profile
contact_page
Contacts
rss_feed
RSS News Feed
account_tree
Sitemap